Fuan Pharmaceutical (Group) Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	no data
Participación del CEO	n/a
Permanencia media de la dirección	15.1yrs
Promedio de permanencia en la Junta Directiva	6.3yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Fuan Pharmaceutical (Group) no tiene CEO, o no tenemos datos al respecto.

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Xue Song Yu	Deputy GM	15.1yrs	CN¥558.90k	0.011% CN¥ 601.3k
Jing Feng	Deputy General Manager	15.1yrs	CN¥561.90k	0.023% CN¥ 1.3m
Rong Chuan Hong	Deputy General Manager	15.1yrs	CN¥496.60k	0.016% CN¥ 880.4k
Yong Ping Sun	Deputy General Manager	4.2yrs	CN¥565.20k	0.025% CN¥ 1.4m
Tao Huang	Deputy GM & Director	11.8yrs	CN¥670.70k	0.74% CN¥ 41.7m
Xionghui Wu	Deputy General Manager	2.8yrs	CN¥561.50k	0.000080% CN¥ 4.5k
Qin Tang	Secretary of the Board of Directors & Director	15.1yrs	CN¥561.90k	0.024% CN¥ 1.4m

15.1yrs

Permanencia media

54yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 300194 es experimentado (14.6 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Xue Song Yu	Deputy GM	15.1yrs	CN¥558.90k	0.011% CN¥ 601.3k
Tao Huang	Deputy GM & Director	11.8yrs	CN¥670.70k	0.74% CN¥ 41.7m
Qin Tang	Secretary of the Board of Directors & Director	15.1yrs	CN¥561.90k	0.024% CN¥ 1.4m
Lu Wang	Vice Chairman	2.8yrs	CN¥687.90k	sin datos
Tianxiang Wang	Chairman	15.1yrs	CN¥875.80k	24% CN¥ 1.4b
Zi Wei Guo	Supervisor	6.3yrs	CN¥197.50k	sin datos
Wei Wang	Director	6.3yrs	CN¥614.00k	sin datos
Wen Shuo Xiong	Independent Director	5.8yrs	CN¥60.00k	sin datos
Shu Zhu	Independent Director	5.8yrs	CN¥60.00k	sin datos
Geng Chen	Independent Director	2.8yrs	CN¥55.00k	sin datos
Yong Yang	Chairman of the Supervisory Board	2.3yrs	sin datos	sin datos

6.3yrs

Permanencia media

54yo

Promedio de edad

Junta con experiencia: La junta directiva de 300194 se considera experimentada (5.8 años de antigüedad promedio).

Fuan Pharmaceutical (Group) Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Fuan Pharmaceutical (Group) Co., Ltd., Annual General Meeting, May 24, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Investor sentiment improves as stock rises 27%

Fuan Pharmaceutical (Group) Co., Ltd. to Report Q3, 2024 Results on Oct 25, 2024

Second quarter 2024 earnings released: EPS: CN¥0.08 (vs CN¥0.07 in 2Q 2023)

Fuan Pharmaceutical (Group) Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024

Fuan Pharmaceutical (Group) Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 04 June 2024

Fuan Pharmaceutical (Group) Co., Ltd. Proposes Final Cash Dividend for 2023

Fuan Pharmaceutical (Group) Co., Ltd., Annual General Meeting, May 24, 2024

First quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.07 in 1Q 2023)

Fuan Pharmaceutical (Group) Co., Ltd. to Report Q1, 2024 Results on Apr 25, 2024

Investor sentiment deteriorates as stock falls 17%

Fuan Pharmaceutical (Group) Co., Ltd. to Report Fiscal Year 2023 Results on Apr 25, 2024

Third quarter 2023 earnings released: EPS: CN¥0.07 (vs CN¥0.04 in 3Q 2022)

Investor sentiment improves as stock rises 19%

Second quarter 2023 earnings released: EPS: CN¥0.07 (vs CN¥0.04 in 2Q 2022)

Fuan Pharmaceutical (Group) Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 12 May 2023

First quarter 2023 earnings released: EPS: CN¥0.07 (vs CN¥0.03 in 1Q 2022)

Now 21% undervalued

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.04 (vs CN¥0.06 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.04 (vs CN¥0.04 in 2Q 2021)

First quarter 2022 earnings released: EPS: CN¥0.03 (vs CN¥0.05 in 1Q 2021)

Less than half of directors are independent

Full year 2021 earnings released: CN¥0.25 loss per share (vs CN¥0.18 profit in FY 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.06 (vs CN¥0.05 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.04 (vs CN¥0.05 in 2Q 2020)

Fuan Pharmaceutical (Group) Co., Ltd. Announces Implementation of Profit Distribution Plan for A Shares for the Year 2020, Payable on 14 May 2021

First quarter 2021 earnings released: EPS CN¥0.05 (vs CN¥0.06 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.18 (vs CN¥0.25 in FY 2019)

Fuan Pharmaceutical (Group) Co., Ltd. to Report Fiscal Year 2020 Results on Mar 31, 2021

New 90-day low: CN¥4.18

New 90-day low: CN¥4.74

New 90-day low: CN¥5.42

New 90-day high - CN¥6.57

Fuan Pharmaceutical (Group) Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020

New 90-day high - CN¥6.27

CEO

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad